Advertisement
Advertisement
U.S. markets open in 6 hours 19 minutes
Advertisement
Advertisement
Advertisement
Advertisement

IMARA Inc. (IMRA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.6300+0.0600 (+1.68%)
At close: 4:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Hammer

Hammer

Previous Close3.5700
Open3.5900
Bid0.0000 x 1300
Ask0.0000 x 800
Day's Range3.5400 - 3.6900
52 Week Range3.4600 - 29.9150
Volume53,612
Avg. Volume193,204
Market Cap95.278M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-2.6940
Earnings DateNov 03, 2021 - Nov 08, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est24.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for IMRA

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • IMARA Inc.
    Daily – Vickers Top Buyers & Sellers for 08/23/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    2 months agoArgus Research
View more
  • GlobeNewswire

    Imara to Participate in Upcoming Investor Conferences

    SVB Leerink CybeRx Series and 2021 Cantor Virtual Global Healthcare ConferenceBOSTON, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin and other serious diseases, today announced that the Company will be present at the following upcoming virtual investor conferences in September: Imara will participa

  • Simply Wall St.

    What Type Of Shareholders Make Up IMARA Inc.'s (NASDAQ:IMRA) Share Registry?

    If you want to know who really controls IMARA Inc. ( NASDAQ:IMRA ), then you'll have to look at the makeup of its share...

  • GlobeNewswire

    Imara to Present at Upcoming Investor Conferences

    Citi 16th Annual BioPharma Virtual Conference, H.C. Wainwright 23rd Annual Global Investment Conference and Morgan Stanley 19th Annual Global Healthcare ConferenceBOSTON, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin and other serious diseases, today announced that the Company will participate in

Advertisement
Advertisement